Company profile

Orion Corporation

Diversified pharma; originator of levosimendan

ORNBV · Nasdaq Helsinki · Finland

Public Market Listing

ORNBVNasdaq Helsinki

Nasdaq Helsinki primary exchange listing

Live quotes, historical charts, and market capitalization for Orion Corporation are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
entacapone(Comtess)
Approved
COMTSmall molecule
Parkinson's Disease
Levosimendan(Simdax)
Approved
Cardiac troponin C (calcium sensitizer)Small molecule
Heart Failure

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.